Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript February 29, 2024 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS is $-0.36 EPS, expectations were $-0.29. FDS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name […]
Horizon Technology Finance Corporation (NASDAQ:HRZN) Q4 2023 Earnings Call Transcript February 28, 2024 Horizon Technology Finance Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Horizon Technology Finance Corporation’s Fourth Quarter 2023 Earnings Call. [Operator […]
Arko Corp. (NASDAQ:ARKO) Q4 2023 Earnings Call Transcript February 28, 2024 Arko Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the Arko Corp. Fourth Quarter and Fiscal Year 2023 Earnings Conference Call. [Operator Instructions] Please note […]